Search results

Jump to: navigation, search

Page title matches

  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    21 KB (2,852 words) - 14:40, 29 January 2015
  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    5 KB (731 words) - 14:51, 20 December 2007
  • #REDIRECT [[Bristol-Myers Squibb: Illegal Activities]]
    54 bytes (5 words) - 12:25, 20 December 2007

Page text matches

  • ...nts include Dow Chemical, the Aspirin Foundation of America, Bristol Myers Squibb, and the National Pharmaceutical Council.<ref>Martin Donohoe, "[http://phsj
    8 KB (1,072 words) - 09:33, 8 April 2015
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    32 KB (4,534 words) - 14:23, 12 July 2016
  • '''Collaborations:''' [[Abbott]], [[ARIAD]], [[BASF]], Bayer, [[Bristol-Myers Squibb]], [[Eli Lilly]], [[Genetech]], [[Hoechst]], [[Hoffmann La-Roche]], [[Johns ...partners include [[Pharmacia]] (about 40% of revenues) and [[Bristol-Myers Squibb]].{{ref|124}}
    50 KB (7,192 words) - 20:24, 3 June 2013
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    33 KB (4,955 words) - 07:16, 19 February 2011
  • ...n the Senate lobbying records for 2003 included Biogen, Inc, Bristol-Myers Squibb, Glaxo Smith Kline, Petroleum Marketers Assn of America, Phrma and NewsCorp
    16 KB (2,237 words) - 09:40, 14 October 2016
  • ...ce | [[Biogen]] Idec MA Inc. | Boehringer Ingelheim GmbH | [[Bristol-Myers Squibb]] Company | Charles River Laboratories | Covance Laboratories, Inc. | Daiic
    27 KB (3,759 words) - 09:52, 31 August 2015
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). His biography goes on to report that he also serves on the
    7 KB (980 words) - 11:16, 10 February 2008
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    3 KB (452 words) - 22:10, 21 December 2017
  • *[[BMS (Bristol-Myers Squibb)]]
    5 KB (560 words) - 19:19, 14 April 2006
  • *Bristol Myers Squibb
    3 KB (328 words) - 12:32, 31 May 2007
  • ...man-Hillard]], is now policy and public affairs manager at [[Bristol-Myers Squibb]]<ref> [https://uk.linkedin.com/pub/richard-robinson/26/902/554 Richard Rob
    37 KB (4,488 words) - 08:44, 25 July 2016
  • *[[Bristol-Myers Squibb]]
    17 KB (2,257 words) - 15:22, 5 May 2016
  • [[Bayer]] | [[Boehringer Ingelheim]] | [[Bristol-Myers Squibb]] | [[GlaxoSmithKline]] | [[Ortho-Biotech]] | [[Merck]] | [[Novartis]] | [[
    3 KB (277 words) - 16:39, 22 October 2014
  • ...lton]], [[Burson Marsteller]], [[Rockwell International]], [[Bristol-Myers Squibb]], [[General Motors]] and [[Nippon Telephone and Telegraph]]. A cooperative
    16 KB (2,361 words) - 14:01, 8 February 2007
  • ...Vice President & President, Worldwide Pharmaceuticals for [[Bristol-Myers Squibb]] * [[Bristol-Myers Squibb]]
    17 KB (2,252 words) - 21:22, 6 December 2010
  • *[[Bristol-Myers Squibb Company]]
    12 KB (1,740 words) - 17:41, 28 March 2008
  • ...petitors are [[Merck]], [[GlaxoSmithKline]], [[Novartis]], [[Bristol Myers Squibb]] and [[AstraZeneca]].
    24 KB (3,261 words) - 14:30, 13 July 2016
  • * [[Bristol-Myers Squibb]] Company
    853 bytes (94 words) - 19:19, 9 January 2008
  • *[[Bristol Myers Squibb]]
    3 KB (288 words) - 07:47, 18 June 2008
  • Bristol Myers Squibb Company Pharmaceutical US
    6 KB (764 words) - 12:37, 9 May 2008

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)